Вы искали: e2b (Английский - Испанский)

cpmp/ich/287/95 (e2b)
cpmp/ewp/552/95

the educational objectives with regard to opinions and values in the e2b initial training programme are as follows:
los objetivos pedagógicos con respecto a las opiniones y los valores del programa de formación inicial de los funcionarios de los grupos e2b son los siguientes:

denmark, hungary and united kingdom (sct): see the additional notes to figure e2b.
dinamarca, hungría y reino unido (sct): ver las notas complementarias de la figura e2b.

in compulsory general secondary education (figure e2b), changes are a little more in evidence between 1992 and 2002.
en la educación secundaria general obligatoria (figura e2b), los cambios son un poco más marcados entre 1992 y 2002.

final guidelines • choice of control group in clinical trials (cpmp/ ich/ 364/ 96), ich e10 • clinical investigation of medicinal products in children (cpmp/ ich/ 2711/ 99), ich e11 • safety pharmacology studies for human pharmaceuticals (cpmp/ ich/ 539/ 00), ich s7a • stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ ich/ 2736/ 99 rev. of cpmp/ ich/ 380/ 95), ich q1ar • non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ ich/ 286/ 95, modification), ich m3 modification • reproductive toxicology: toxicity to male fertility (cpmp/ ich/ 136/ 95 modification), ich s5b modification • data elements for transmission of individual case safety reports (cpmp/ ich/ 287/ 95 modification), ich e2b • recommendations on electronic transmission of individual case safety reports message specification (cpmp/ ich/ 285/ 95), ich m2 • good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ ich/ 4106/ 00), ich q7a • common technical document (ctd), (cpmp/ ich/ 2887/ 99), ich m4
directrices definitivas • choice of control group in clinical trials (cpmp/ich/364/96), ich e10. • clinical investigation of medicinal products in children (cpmp/ich/2711/99), ich e11. • safety pharmacology studies for human pharmaceuticals (cpmp/ich/539/00), ich s7a. • stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ich/2736/99 rev. of cpmp/ich/380/95), ich q1ar. • non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ich/286/95, modification), ich m3 modification. • reproductive toxicology: toxicity to male fertility (cpmp/ich/136/95 modification), ich s5b modification. • data elements for transmission of individual case safety reports (cpmp/ich/287/95 modification), ich e2b. • recommendations on electronic transmission of individual case safety reports message specification (cpmp/ich/285/95), ich m2. • good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ich/4106/00), ich q7a. • common technical document (ctd) (cpmp/ich/2887/99), ich m4.